FDA Brief

Company record

TRYM Health, Inc. dba TRYM Health

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about TRYM Health, Inc. dba TRYM Health.

Warning letters

  1. TRYM Health, Inc. dba TRYM Health

    FDA told telehealth seller TRYM Health its website claims for compounded semaglutide and tirzepatide are false and misleading, making the drugs misbranded.

    Medium